We are familiar with the stock picking prowess of Amitabh Bachchan and Kabir Bedi, both of whom have surprised us with mega bagger gains. Kimi Katkar, the yesteryear heartthrob, has joined the elite club with a stunning 32-bagger stock to her credit
Subscribe to Blog via Email
Join 494 other subscribers
- Power Grid is trading at attractive valuation with dividend yield of 4.3%. TP ₹426 (36%)Power Grid has 50-60% market share in Inter-State Transmission Systems. Total capex potential is ₹6.6T. It is well placed to execute 6 upcoming HVDC & 3 cross-border projects. Co is trading at attractive valuation with dividend yield of 4.3%. TP ₹426 (36%) Download research report... Power Grid is trading at attractive valuation with dividend yield […]
- AVALON's long-term revenue trajectory will continue to be strong. TP ₹920 (+30%)AVALON's long-term revenue trajectory will continue to be strong due to 1) the addition of new customers in the US & Indian markets & 2) order inflows from high-growth/high-margin industries such as Clean Energy, Mobility & Industrials. TP ₹920 (+30%) Download research report... AVALON's long-term revenue trajectory will continue to be strong. TP ₹920 (+30%)
- Yatharth is trading at comforting valuations. Buy for TP ₹790 (30%)Yatharth is trading at comforting valuations. Given significant growth opportunities in local market & its pledge to increase revenue without sacrificing return ratios, there's a clear sign that gap in valuation from peers is likely to wane. TP ₹790 (30%) Download research report ... Yatharth is trading at comforting valuations. Buy for TP ₹790 (30%)
Recent Posts
- Power Grid is trading at attractive valuations with a dividend yield of 4.3%. Buy for target price of ₹426 (36% upside): Motilal Oswal
- Saurabh Mukherjea’s Marcellus Fund has added 5 stocks to the Rising Giants PMS portfolio
- Avalon Technologies is expected to show strong revenue and profitability. Buy for target price of ₹920 (+30% upside): Motilal Oswal
- Yatharth Hospital has significant growth opportunities. Buy for target price of ₹790 (30% upside): SMIFS
- J.B. Chemicals is well-positioned to capitalize on immediate growth opportunities. Buy for target price of ₹2217 (19% upside): SMIFS
Recent Comments